CCL

Összesen 4 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:bibEBI00026273
035-os BibID:(cikkazonosító)E3050 (WoS)000581708900001 (Scopus)85108175368
Első szerző:Bagoly Zsuzsa (orvos)
Cím:Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists during Cryoballoon Catheter Ablation of Atrial Fibrillation / Zsuzsa Bagoly, Orsolya Hajas, Réka Urbancsek, Alexandra Kiss, Edit Fiak, Ferenc Sarkady, Noémi Klára Tóth, Rita Orbán-Kálmándi, Kitti Bernadett Kovács, László Nagy, Attila Nagy, János Kappelmayer, László Csiba, Zoltán Csanádi
Dátum:2020
ISSN:2077-0383
Megjegyzések:Background. Cerebral thromboembolism is a rare but feared complication of transcatheter ablation in patients with atrial fibrillation (AF). Here, we aimed to test which pre-procedural anticoagulation strategy results in less intracardiac activation of hemostasis during ablation. Patients and methods. In this observational study, 54 paroxysmal / persistent AF patients undergoing cryoballoon ablation were grouped according to their periprocedural anticoagulation strategy: no anticoagulation (oral anticoagulation (OAC) free; n = 24), uninterrupted vitamin K antagonists (VKA) ( n = 11), uninterrupted dabigatran ( n = 17). Blood was drawn from the left atrium before and immediately after the ablation procedure. Cryoablations were performed according to standard protocols, during which heparin was administered. Heparin-insensitive markers of hemostasis and endothelial damage were tested from intracardiac samples: D-dimer, quantitative fibrin monomer (FM), plasmin-antiplasmin complex (PAP), von Willebrand factor (VWF) antigen, chromogenic factor VIII (FVIII) activity. Results. D-dimer increased significantly in all groups post-ablation, with lowest levels in the dabigatran group (median [interquartile range]: 0.27 [0.36] vs. 1.09 [1.30] and 0.74 [0.26] mg / L in OAC free and uninterrupted VKA groups, respectively, p < 0.001 ). PAP levels were parallel to this observation. Post-ablation FM levels were elevated in OAC free ( 26.34 [30.04] mg / L ) and VKA groups (10.12 [16.01] mg / L), but remained below cut-o in all patients on dabigatran ( 3.98 [2.0] mg / L; p < 0.001). VWF antigen and FVIII activity increased similarly post-ablation in all groups, suggesting comparable procedure-related endothelial damage. Conclusion. Dabigatran provides greater inhibition against intracardiac activation of hemostasis as compared to VKAs during cryoballoon catheter ablation.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
atrial fibrillation
cryoballoon ablation;
dabigatran
vitamin K antagonists
Megjelenés:Journal of Clinical Medicine. - 9 : 9 (2020), p. 1-13. -
További szerzők:Hajas Orsolya (1987-) Urbancsek Réka (1991-) (általános orvos) Kiss Alexandra (1987-) (általános orvos) Fiák Edit Sarkady Ferenc (1982-) (laboratóriumi analitikus) Tóth Noémi Klára Orbán-Kálmándi Rita Angéla (1993-) (klinikai laboratóriumi kutató) Kovács Kitti Bernadett (1985-) (neurológus) Nagy László Tibor (1969-) (belgyógyász, kardiológus) Nagy Attila Csaba (1981-) (megelőző orvostan és népegészségtan szakorvos, epidemiológus) Kappelmayer János (1960-) (laboratóriumi szakorvos) Csiba László (1952-) (neurológus, pszichiáter) Csanádi Zoltán (1960-) (kardiológus)
Pályázati támogatás:GINOP-2.3.2-15-2016-00043
GINOP
MTA-DE
MTA
K109712
OTKA
K120042
OTKA
FK128582
OTKA
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM116479
035-os BibID:(cikkazonosító)6829 (scopus)85176548280 (WoS)001099491300001
Első szerző:Illési Ádám (orvos)
Cím:Technically Challenging Percutaneous Interventions of Chronic Total Occlusions Are Associated with Enhanced Platelet Activation / Illési Ádám, Fejes Zsolt, Pócsi Marianna, Debreceni Ildikó Beke, Hodosi Katalin, Nagy Jr. Béla, Kappelmayer János, Kőszegi Zsolt, Csanádi Zoltán, Szük Tibor
Dátum:2023
ISSN:2077-0383
Megjegyzések:Percutaneous coronary intervention (PCI) is a frequently performed treatment option for recanalization in patients with chronic total occlusion (CTO). As CTO-PCIs are often complicated and challenging for interventionalists, the stressful and damaging nature of the procedure can be remarkable, thus platelets can be easily activated. Our aim was to investigate the effect of CTO-PCI on platelet activation and the expression of selected circulating microRNAs (miR) of platelet and endothelium origin after CTO-PCI. In this study, 50 subjects after CTO-PCI were enrolled. Blood samples were obtained before PCI, at 2 days and 3?6 months after the procedure to measure the degree of platelet activation and the level of plasma miR-223, miR-181b, and miR-126. Patients were divided based on the characteristics of the intervention. Patients with higher Japanese CTO scores and longer duration of PCI showed significantly elevated platelet P-selectin positivity (p = 0.004 and p = 0.013, respectively) 2 days after the procedure compared to pre-PCI and increased concentration of soluble P-selectin 3?6 months after the intervention (higher Japanese CTO score: p = 0.028 and longer duration of PCI: p = 0.023) compared to baseline values. Shorter total stent length caused a significantly lower miR-181b expression at 3?6 months after the intervention (p = 0.031), while no difference was observed in miR-223 and miR-126. One stent thrombosis occurred during the follow-up period. Although these technically challenging CTO-PCIs may cause enhanced platelet activation right after the intervention and long-term endothelial cell dysfunction, these interventions are not associated with more adverse clinical events.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
biomarker
chronic total coronary occlusion
coronary intervention
microRNA
platelet activation
Megjelenés:Journal of Clinical Medicine. - 12 : 21 (2023), p. 1-14. -
További szerzők:Fejes Zsolt (1988-) (molekuláris biológus) Pócsi Marianna (1989-) (klinikai laboratóriumi kutató) Bekéné Debreceni Ildikó (1970-) (biológus) Hódosi Katalin Nagy Béla Jr. (1980-) (labordiagnosztikai szakorvos) Kappelmayer János (1960-) (laboratóriumi szakorvos) Kőszegi Zsolt (1962-) (kardiológus, belgyógyász) Csanádi Zoltán (1960-) (kardiológus) Szűk Tibor (1967-) (kardiológus)
Pályázati támogatás:GINOP-2.3.2-15-2016-00043
GINOP
ÚNKP-22-4-II-DE-120
Egyéb
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

3.

001-es BibID:BIBFORM103445
035-os BibID:(Scopus)85135072664 (Wos)000838536900011
Első szerző:Illési Ádám (orvos)
Cím:Effect of invasive therapeutic coronary interventions on endothelial cell activation and thrombin generation in patients with chronic total coronary occlusion / Illési Ádám, Debreceni Ildikó Beke, Fejes Zsolt, Nagy Béla, Hodosi Katalin, Kappelmayer János, Csanádi Zoltán, Szük Tibor István
Dátum:2022
ISSN:0049-3848
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Thrombosis Research. - 217 (2022), p. 64-72. -
További szerzők:Bekéné Debreceni Ildikó (1970-) (biológus) Fejes Zsolt (1988-) (molekuláris biológus) Nagy Béla Jr. (1980-) (labordiagnosztikai szakorvos) Hódosi Katalin Kappelmayer János (1960-) (laboratóriumi szakorvos) Csanádi Zoltán (1960-) (kardiológus) Szűk Tibor (1967-) (kardiológus)
Pályázati támogatás:GINOP-2.3.2-15-2016-00043
GINOP
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

4.

001-es BibID:BIBFORM112604
035-os BibID:(cikkazonosító)171 (WoS)001025509200007 (Scopus)85164313047
Első szerző:Szuromi Lilla (kardiológus)
Cím:Long-Term Changes in the Biomarkers of Left Atrial Fibrosis after Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation / Lilla Szuromi, Orsolya Hajas, Edina Nagy-Baló, Ildikó N. Forgács, László T. Nagy, Miklós Fagyas, Attila Tóth, Béla Nagy Jr., János Kappelmayer, Zoltán Csanádi
Dátum:2023
ISSN:1530-6550 2153-8174
Megjegyzések:Background: Atrial fibrillation (AF) is accompanied by inflammation and fibrosis to variable extent. The biomarkers of fibrosis were measured in patients with different forms of AF and cardiac status. Herein, we assessed the associations of the baseline concentrations of different biomarkers with the long-term success of pulmonary vein isolation (PVI) in patients with a structurally normal heart. Fur-thermore, we compared biomarker levels before and 3 years after ablation to gain further insights into the AF mechanism. Methods: Patients, undergoing PVI for paroxysmal/persistent AF were enrolled prospectively. Blood samples were obtained 24 hours before and 3 years after ablation. Serum cancer antigen 125 (CA-125), plasma Caspase-3, Galectin-3 and Cathepsin L concentrations were measured. Follow-up visits every 6 months included 12-lead electrocardiogram, 24-hour Holter, trans-telephonic monitoring as well as transtho-racic echocardiography after ablation. Biomarker levels, left ventricular ejection fraction and left atrial (LA) diameters at baseline and at the 3-year follow-up were compared in patients with versus without AF recurrence. Results: A total of 63 patients were enrolled (23 women; age 61.4 (& PLUSMN; 8.8) years). The acute isolation of all pulmonary veins was achieved in all patients. During a mean follow-up of 36.3 & PLUSMN; 6.3 months, AF recurrence was demonstrated in 26 (41.3%) patients. No significant differences were demonstrated in the levels of CA-125, Galectin-3, Caspase-3 and Cathepsin L pre-and post-ablation in patients with versus without AF recurrence. A significant decrease was detected in the concentrations of Caspase-3, Galectin-3 and Cathepsin L during follow-up with no difference in patients with versus without AF recurrence. A positive correlation was found between Caspase-3 levels and LA diameters in the AF recurrence group both before (r = 0.477; p = 0.018) and after the procedure (r = 0.533; p = 0.019). Conclusions: Our results demonstrated that the levels of CA-125, Caspase-3, Cathepsin L and Galectin-3 are not associated with AF recurrence after PVI in patients with a structurally normal heart and mainly paroxysmal AF. Except for CA-125, all the other biomarkers demonstrated a significant decrease during a 3 -year follow-up post-ablation. Furthermore, Caspase-3 levels demonstrated a positive correlation with LA dimensions in patients with AF recurrence.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Reviews in Cardiovascular Medicine. - 24 : 6 (2023), p. 171. -
További szerzők:Hajas Orsolya (1987-) Nagy-Baló Edina (1985-) (kardiológus) Forgács Ildikó Noémi (1992-) (biológus) Nagy László, T. (1974-) (informatikus) Fagyas Miklós (1984-) (orvos) Tóth Attila (1971-) (biológus) Nagy Béla Jr. (1980-) (labordiagnosztikai szakorvos) Kappelmayer János (1960-) (laboratóriumi szakorvos) Csanádi Zoltán (1960-) (kardiológus)
Internet cím:DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1